You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cholinesterase Inhibitors

Showing 1 - 25 of 4,274
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Amblyopia Trial in Boston, Waltham, Weymouth (Donepezil, Patching)

Completed
  • Amblyopia
  • Boston, Massachusetts
  • +2 more
Jun 16, 2021

Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)

Not yet recruiting
  • Alzheimer Disease
  • Placebo
  • +2 more
  • Paris, France
    Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
Sep 29, 2022

Mental Health, Geriatrics Trial in Thunder Bay, Toronto (donepezil, Placebo (cornstarch))

Completed
Has Results
  • Mental Health
  • Geriatrics
  • Thunder Bay, Ontario, Canada
  • +1 more
Feb 13, 2019

Alzheimer Trial in Korea, Republic of (Choline Alfoscerate 400mg, Placebo)

Recruiting
  • Alzheimer Disease
  • Choline Alfoscerate 400mg
  • Placebo
  • Changwon, Korea, Republic of
  • +3 more
May 16, 2022

Myasthenia Gravis Trial in GuangZhou (Azathioprine, Leflunomide)

Completed
  • Myasthenia Gravis
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital, SUN YAT-SEN UNIVERSITY
Apr 6, 2022

Dementia Trial in Porto (Treatment withdrawal)

Completed
  • Dementia
  • Treatment withdrawal
  • Porto, Portugal
    Centro Hospitalar Universitário de São João
Apr 4, 2022

Healthy Volunteers Trial in Baltimore (BNC, Placebo)

Completed
  • Healthy Volunteers
  • Baltimore, Maryland
    National Institute on Aging, Clinical Research Unit
Feb 2, 2023

A Prospective Cohort Study of Myasthenia Gravis in China

Recruiting
  • Myasthenia Gravis
  • Steroid Drug
  • Withdraw all immunosuppresants
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 17, 2023

Parkinson Disease Trial in United Kingdom (Rivastigmine Transdermal System, Placebo Transdermal System)

Recruiting
  • Parkinson Disease
  • Rivastigmine Transdermal System
  • Placebo Transdermal System
  • Romford, Accepted, United Kingdom
  • +26 more
Dec 22, 2021

Refractory Myasthenia Gravis, Rituximab Trial in Guangzhou (Rituximab)

Recruiting
  • Refractory Myasthenia Gravis
  • Rituximab
  • Guangzhou, China
    First Affiliated Hospital, Sun Yat-Sen University
Apr 26, 2022

Bilateral Sensorineural Hearing Loss Trial (Donepezil, Placebo)

Not yet recruiting
  • Bilateral Sensorineural Hearing Loss
  • (no location specified)
Jul 7, 2022

Thoracal Epidural Block Trial in Van (Neuromuscular block)

Completed
  • Thoracal Epidural Block
  • Neuromuscular block
  • Van, Turkey
    Arzu Esen Tekeli
Jun 15, 2023

Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative Trial (Sugammadex, Neostigmine,

Not yet recruiting
  • Spine Surgery
  • +2 more
  • (no location specified)
May 24, 2023

Alzheimer Trial in San Antonio (Dasatinib + Quercetin)

Active, not recruiting
  • Alzheimer Disease
  • Dasatinib + Quercetin
  • San Antonio, Texas
    Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseas
Jun 30, 2022

Parkinson Disease, Memory Disorders Trial in Toronto (NBM stimulation using the Vercise device (Boston Scientific, Marlborough,

Completed
  • Parkinson Disease
  • Memory Disorders
  • NBM stimulation using the Vercise device (Boston Scientific, Marlborough, Massachusetts, US)
  • Toronto, Ontario, Canada
    Toronto Western Hospital
Nov 1, 2022

EEG-cholinergic Index and Clinical Response to Treatment With

Unknown status
  • Alzheimer´s Disease
    • (no location specified)
    Aug 16, 2018

    Tobacco Use Disorder Trial in Philadelphia (Galantamine, Placebo)

    Completed
    Has Results
    • Tobacco Use Disorder
    • Philadelphia, Pennsylvania
      Center for Interdisciplinary Research on Nicotine Addiction, Uni
    Jan 22, 2019

    Repetitive Transcranial Magnetic Stimulation Trial in Hefei (? burst transcranial magnetic stimulation, Pharmacotherapy)

    Completed
    • Repetitive Transcranial Magnetic Stimulation
    • Hefei, Anhui, China
      Cognitive Neuropsychology Lab Anhui Medical University
    Jul 2, 2022

    Cerebral Small Vessel Diseases Trial in Guangzhou (mouse nerve growth factor)

    Unknown status
    • Cerebral Small Vessel Diseases
    • mouse nerve growth factor
    • Guangzhou, Guangdong, China
      Zhujiang Hospiatal
    Oct 30, 2020

    Dementia Trial in United States (Cholinesterase inhibitor, Sham discontinuation)

    Completed
    Has Results
    • Dementia
    • Cholinesterase inhibitor
    • Sham discontinuation
    • Little Rock, Arkansas
    • +3 more
    Sep 29, 2020

    Presbycusis, Tinnitus, Cognitive Impairment Trial in Shanghai (BTHE and Huperzine A, BETH)

    Enrolling by invitation
    • Presbycusis
    • +2 more
    • BTHE and Huperzine A
    • BETH
    • Shanghai, Shanghai, China
      Huadong Hospital
    Mar 16, 2022

    Alzheimer and Related Dementias (ADRD) Trial in Boca Raton (Passive Digital Marker for screening for ADRD)

    Recruiting
    • Alzheimer Disease and Related Dementias (ADRD)
    • Passive Digital Marker for screening for ADRD
    • Boca Raton, Florida
    • +1 more
    Sep 7, 2022

    Organophosphorus Poisoning Trial (Intralipid, 20% Intravenous Emulsion, Intravenous Atropine Sulfate)

    Not yet recruiting
    • Organophosphorus Poisoning
    • Intralipid, 20% Intravenous Emulsion
    • Intravenous Atropine Sulfate
    • (no location specified)
    Nov 8, 2021

    Parkinson Disease, Cognitive Impairment Trial in Richmond (Istradefylline)

    Recruiting
    • Parkinson Disease
    • Cognitive Impairment
    • Richmond, Virginia
      Virginia Commonwealth University
    Aug 10, 2022

    Cholinesterase Inhibitors in Alzheimer's Disease After Three

    Completed
    Has Results
    • Late Onset Alzheimer
      • (no location specified)
      Jun 7, 2018